We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Genentech, a pharmaceutical company of the Roche, has secured the US Food and Drug Administration (FDA) approval of Venclexta (venetoclax) plus azacitidine to treat a type of acute
Eli Lilly and Company (Lilly) has agreed to acquire Disarm Therapeutics, a biotechnology firm developing advanced disease-modifying drugs for axonal degeneration. Axonal degeneration is a common, yet unaddressed,
Seattle Gummy Company (SGC) has received the FDA Investigational New Drug Application (IND) approval for allergy medication, delivered through gummies. The nutraceutical firm has started its gummy drug
Regeneron Pharmaceuticals has secured the US Food and Drug Administration (FDA) approval for its antibody cocktail Inmazeb to treat Ebola virus (Zaire ebolavirus) infection in patients of all
The World Bank (WB) has approved $12bn financing for developing countries to support the purchase and distribute Covid-19 vaccines, tests, and treatments. The financing programme, part of the
Novartis has secured the European Medicines Agency (EMA) PRIME designation for its iptacopan (LNP023) to treat C3 glomerulopathy (C3G). C3G is a very rare and severe form of
Bristol Myers Squibb has unveiled results from its Phase 3 True North clinical trial, evaluating Zeposia (ozanimod) as an oral induction and maintenance therapy for moderate to severe
Japan-based pharmaceutical firm Takeda has signed a collaboration and licensing agreement with US-based Arrowhead Pharmaceuticals, for ARO-AAT to treat a type of liver disease. Under the terms of
Johnson & Johnson (J&J) has announced that the European Commission (EC) has approved the supply 200 million doses of Janssen Pharmaceutical’s Covid-19 vaccine candidate to EU Member States.
Abbott has unveiled new interim analyses from the study results of its rapid Covid-19 test ID NOW, which showed an overall sensitivity of 93.3% and specificity of 98.4%.